News & Analysis on Clinical Trial Services & Contract Research And Development
Breckenridge Pharmaceutical has entered into a multi-product marketing agreement with development and manufacturing partner Gland Pharma Limited for seven injectable products.
Fake erectile dysfunction drugs found in Serbian coaches entering Switzerland were made in India according to regulator Swissmedic.
Merck has launched a polyvinyl alcohol-based excipient developed for use in drugs produced via hot melt extrusion (HME).
MULTIPLE MYELOMA
Takeda was awarded conditional EU marketing authorisation of the small molecule drug Ninlaro, overturning the EMA’s negative opinion on its efficacy against Multiple Myeloma (MM).
AstraZeneca has partnered with Bicycle Therapeutics in a potential $1bn deal to develop a new class of small molecules which have antibody-like properties.
UK based clinical research organization (CRO), Ergomed, has bought out the Czech PharmInvent as a ‘bolt on’ to its own pharmacovigilance subsidiary, PrimeVigilance.
Celgene has made a second investment in a machine learning and simulation platform for applications across drug discovery, clinical development, and commercialization.
The US FDA has asked Spanish API firm Interquim S.A. for more details of its plan to bring its Barcelona manufacturing plant up to code.
Charles River Laboratories has announced an "end-to-end" service offering of CRISPR/Cas9 genome engineering technology, including custom in vivo and in vitro genome editing.
The development partnership has been extended as GlaxoSmithKline looks to make clinical trial scale batches using Puridify’s Protein A alternative to packed bed chromatography columns.